95 research outputs found

    Performance of Indian spinach and papaya in litchi based agroforestry system

    Get PDF
    An investigation was conducted at Borjona village of Kapasia, Gazipur district during September 2011 to October 2012 to examine the biological performance of Indian spinach and papaya in litchi based agroforestry system. Papaya was planted between two litchi plants in each line and Indian spinach varieties were grown in the inter-space of two lines of litchi plant as well as control (farmers practice) in May 2012. Yield and yield contributing characters of Indian spinach varieties grown as litchi-papaya based agroforestry system and control did not vary. However, sprout plant-1 and sprout weight of Indian spinach varieties grown in litchi-papaya based system were significantly influenced while the other parameters did not vary. Sprout plant-1 of KS green (2.97) and local (2.89) variety were identical but higher over KS red variety (2.57). Sprout weight of KS red variety was the highest (85.80 g) while KS green and local variety gave lower and identical sprout weight. Though the yield did not vary among the varieties, KS red gave the highest yield (36.32 t ha- 1) followed by local (34.61 t ha-1) and KS green (34.00 t ha-1). In case of growth of litchi, plant height and stem diameter increment were 21.39 and 44.94 % over the eleven months observation period. The yield of papaya was quite satisfactory with an average 42 fruits per plant with 23.71 t ha-1. Therefore, in the Litchi-Papaya-Indian spinach based system, Indian spinach varieties could be ranked as KS red > Local> KS green.Int. J. Agril. Res. Innov. & Tech. 6 (1): 34-40, June, 201

    Analytical Study of Modified RSA Algorithms for Digital Signature

    Get PDF
    Digital signature has been providing security services to secure electronic transaction. Rivest Shamir Adleman (RSA) algorithm was most widely used to provide security technique for many applications, such as e-mails, electronic funds transfer, electronic data interchange, software distribution, data storage, electronic commerce and secure internet access. In order to include RSA cryptosystem proficiently in many protocols, it is desired to formulate faster encryption and decryption operations. This paper describes a systematic analysis of RSA and its variation schemes for Digital Signature. DOI: 10.17762/ijritcc2321-8169.15031

    Effect of long term fertilization on soil respiration and enzyme activities in floodplain soil

    Get PDF
    In agricultural farming system organic manuring and inorganic fertilizer application are the most common agricultural practices. Different fertilizer application lead to differences in soil nutrients, pH, and microbial species, which in turn affect the transformation and decomposition of organic carbon by soil microorganisms. Therefore, a laboratory incubation study was carried out to investigate the influence of long term manuring and fertilization on soil respiration by means of C mineralization and enzyme activities. A parallel first- and zero-order kinetic model was used to describe observed C mineralization in soil. The annual carbon mineralization was found to be significantly influenced by different fertilizer. This result indicates that more stable organic matter was formed in NP treated soil which is less prone to decomposition if present crop management has been changed. Other ward, NP has the highest potentiality to soil for the purpose of carbon sequestration in floodplain soil compared to other fertilizer. Urease activities varied from 4.7µg NH4-N/g soil/2h in NK treatment to 25.7µg NH4-N/g soil/2h in N+FYM treatment. N treatment had a significantly higher urease activity compared to the respective controls. When P, K, S and PK applied separately with N then the treatments show low enzyme activity to control and other treatments (N, N+FYM and NPKSZn). There were no significant differences for Arylamidase activities among the treatments. The arylamidase activities decreased when S applied in combination with N. On the other hand arylamidase activity increased with the application of all other treatment

    The Reverse Brazil Nut Problem: Competition between Percolation and Condensation

    Full text link
    In the Brazil nut problem (BNP), hard spheres with larger diameters rise to the top. There are various explanations (percolation, reorganization, convection), but a broad understanding or control of this effect is by no means acheived. A theory is presented for the crossover from the BNP to the reverse Brazil nut problem (RBNP) based on a competition between the percolation effect and the condensation of hard spheres. The crossover condition is determined, and the theoretical predictions are compared to Molecular Dynamics simulations in two and three dimensions.Comment: 9 pages which includes 7 figure

    Walking to work in Canada: health benefits, socio-economic characteristics and urban-regional variations

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>There is mounting concern over increasing rates of physical inactivity and overweight/obesity among children and adult in Canada. There is a clear link between the amount of walking a person does and his or her health. The purpose of this paper is to assess the health factors, socio-economic characteristics and urban-regional variations of walking to work among adults in Canada.</p> <p>Methods</p> <p>Data is drawn from two cycles of the Canadian Community Health Survey: 2001 and 2005. The study population is divided into three groups: non-walkers, lower-duration walkers and high-duration walkers. Logistic regression modeling tests the association between levels of walking and health related outcomes (diabetes, high blood pressure, stress, BMI, physical activity), socio-economic characteristics (sex, age, income, education) and place of residence (selected Census Metropolitan Areas).</p> <p>Results</p> <p>In 2005, the presence of diabetes and high blood pressure was not associated with any form of walking. Adults within the normal weight range were more likely to be high-duration walkers. Females and younger people were more likely to be lower-duration walkers but less likely to be high-duration walkers. There was a strong association between SES (particularly relative disadvantage) and walking to work. In both 2001 and 2005, the conditions influencing walking to work were especially prevalent in Canada's largest city, Toronto, as well as in several small to medium sized urban areas including Halifax, Kingston, Hamilton, Regina, Calgary and Victoria.</p> <p>Conclusion</p> <p>A number of strategies can be followed to increase levels of walking in Canada. It is clear that for many people walking to work is not possible. However, strategies can be developed to encourage adults to incorporate walking into their daily work and commuting routines. These include mass transit walking and workplace walking programs.</p

    Serum magnesium and calcium levels in relation to ischemic stroke : Mendelian randomization study

    Get PDF
    ObjectiveTo determine whether serum magnesium and calcium concentrations are causally associated with ischemic stroke or any of its subtypes using the mendelian randomization approach.MethodsAnalyses were conducted using summary statistics data for 13 single-nucleotide polymorphisms robustly associated with serum magnesium (n = 6) or serum calcium (n = 7) concentrations. The corresponding data for ischemic stroke were obtained from the MEGASTROKE consortium (34,217 cases and 404,630 noncases).ResultsIn standard mendelian randomization analysis, the odds ratios for each 0.1 mmol/L (about 1 SD) increase in genetically predicted serum magnesium concentrations were 0.78 (95% confidence interval [CI] 0.69-0.89; p = 1.3 7 10-4) for all ischemic stroke, 0.63 (95% CI 0.50-0.80; p = 1.6 7 10-4) for cardioembolic stroke, and 0.60 (95% CI 0.44-0.82; p = 0.001) for large artery stroke; there was no association with small vessel stroke (odds ratio 0.90, 95% CI 0.67-1.20; p = 0.46). Only the association with cardioembolic stroke was robust in sensitivity analyses. There was no association of genetically predicted serum calcium concentrations with all ischemic stroke (per 0.5 mg/dL [about 1 SD] increase in serum calcium: odds ratio 1.03, 95% CI 0.88-1.21) or with any subtype.ConclusionsThis study found that genetically higher serum magnesium concentrations are associated with a reduced risk of cardioembolic stroke but found no significant association of genetically higher serum calcium concentrations with any ischemic stroke subtype

    Stroke genetics informs drug discovery and risk prediction across ancestries

    Get PDF
    Previous genome-wide association studies (GWASs) of stroke — the second leading cause of death worldwide — were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis3, and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach4, we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry5. Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries

    Stroke genetics informs drug discovery and risk prediction across ancestries

    Get PDF
    Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry(1,2). Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis(3), and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach(4), we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry(5). Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries.</p

    Stroke genetics informs drug discovery and risk prediction across ancestries

    Get PDF
    Previous genome-wide association studies (GWASs) of stroke — the second leading cause of death worldwide — were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis3, and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach4, we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry5. Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries
    corecore